Hepatitis B DNA vaccine - PowderMed
Alternative Names: Hepatitis B therapeutic vaccine - PowderMed; pdpSC 18; pPWRG 7128Latest Information Update: 04 Nov 2017
At a glance
- Originator PowderMed
- Developer Pfizer
- Class DNA vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Hepatitis-B in Hong Kong (Intradermal)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Hepatitis-B in Singapore (Intradermal)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Hepatitis-B in Taiwan (Intradermal)